loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Approved Drug Products containing 202229 listed in the FDA Orange Book. Original Data : FDA Website

    Client Virtual Booth
    Menu

    Glenmark Pharmaceuticals

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 GLENMARK PHARMS LTD (1)

    filter

    01 TABLET, DELAYED RELEASE;ORAL (1)

    filter

    01 RX (1)

    filter

    01 ACAMPROSATE CALCIUM (1)

    filter

    01 No (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    ACAMPROSATE CALCIUM

    PDF Supplier PDF
    URL Supplier Web Content
    TABLET, DELAYED RE...
    333MG
    2013-07-16
    202229
    ACAMPROSATE CALCIU...
    RX
    No
    AB
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for FDA Orange Book APPLICATION 202229

    Looking for FDA Orange Book APPLICATION 202229 1

    19

    Glenmark Pharmaceuticals, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

    One of their notable products is ACAMPROSATE CALCIUM, with a corresponding application number 202229.

    Regulatory Information RX

    With a dosage strength 333MG

    Dosage Form Route TABLET, DELAYED RELEASE; ORAL

    Reference Listed Drug No

    Approved since 2013-07-16

    Therapeutic Equivalence (TE) Code AB

    Post Enquiry
    POST ENQUIRY